In response to the recent decision by the FDA to decline the Biogen-partnered dr...
Bristol Myers Squibb is actively working to shed light on the intricate realitie...
In a large Phase 3 trial that enrolled over 17,600 participants aged 45 and olde...
Biogen announced an agreement worth an estimated $7.3 billion to acquire Reata P...
Amgen has announced successful results from a late-stage clinical trial for its ...
Aravive has encountered a significant setback as its phase 3 clinical trial for ...
Terumo Blood and Cell Technologies have introduced the Reveos system, an automat...
Everest Medicines and Calliditas recently completed patient enrollment for the C...
AstraZeneca is undergoing significant transformations, as evidenced by a series ...
The FDA has recently taken action by issuing a Class I recall for the miniaturiz...
Quest Diagnostics has recently introduced a new blood test designed to detect ea...
Octapharma, a leading biopharmaceutical company, has achieved a significant mile...
GSK Plc announced on Monday that ViiV Healthcare, its subsidiary focused on HIV ...
In order to make Cabenuva the conventional treatment choice for HIV, Johnson & J...
Continuous glucose monitors (CGMs) have become a breakthrough in diabetes manage...
Eli Lilly announced that its experimental obesity medicine helped patients lose ...
